672 related articles for article (PubMed ID: 2459290)
1. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
[TBL] [Abstract][Full Text] [Related]
2. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes.
Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE
J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070
[TBL] [Abstract][Full Text] [Related]
3. Functional CD2 mutants unable to bind to, or be stimulated by, LFA-3.
Wolff HL; Burakoff SJ; Bierer BE
J Immunol; 1990 Feb; 144(4):1215-20. PubMed ID: 1689346
[TBL] [Abstract][Full Text] [Related]
4. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
[TBL] [Abstract][Full Text] [Related]
5. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor.
Bockenstedt LK; Goldsmith MA; Dustin M; Olive D; Springer TA; Weiss A
J Immunol; 1988 Sep; 141(6):1904-11. PubMed ID: 2459194
[TBL] [Abstract][Full Text] [Related]
6. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
7. Analysis of CD4 and CD2 receptor function.
Goldman SJ; Bierer BE; Burakoff SJ
Princess Takamatsu Symp; 1988; 19():149-60. PubMed ID: 2908352
[TBL] [Abstract][Full Text] [Related]
8. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells.
Chong AS; Jiang XL; Scuderi P; Lamas M; Graf LH
Cancer Immunol Immunother; 1994 Aug; 39(2):127-34. PubMed ID: 7519126
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody to LFA-3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins.
Bierer BE; Golan DE; Brown CS; Herrmann SH; Burakoff SJ
Eur J Immunol; 1989 Apr; 19(4):661-5. PubMed ID: 2471647
[TBL] [Abstract][Full Text] [Related]
10. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function.
Moingeon P; Chang HC; Wallner BP; Stebbins C; Frey AZ; Reinherz EL
Nature; 1989 May; 339(6222):312-4. PubMed ID: 2566919
[TBL] [Abstract][Full Text] [Related]
11. Requirement for both the CD3/T cell receptor complex and the CD2/lymphocyte function-associated antigen-3 adhesion system in monocyte-independent T cell activation by oxidized erythrocytes.
Prince HE
Immunol Invest; 1989; 18(9-10):1081-93. PubMed ID: 2482251
[TBL] [Abstract][Full Text] [Related]
12. Stimulator cell-dependent requirement for CD2- and LFA-1-mediated adhesions in T lymphocyte activation by superantigenic toxins.
Mittrücker HW; Fleischer B
Cell Immunol; 1992 Jan; 139(1):108-17. PubMed ID: 1370253
[TBL] [Abstract][Full Text] [Related]
13. The structural biology of CD2.
Moingeon P; Chang HC; Sayre PH; Clayton LK; Alcover A; Gardner P; Reinherz EL
Immunol Rev; 1989 Oct; 111():111-44. PubMed ID: 2576417
[TBL] [Abstract][Full Text] [Related]
14. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.
Miller GT; Hochman PS; Meier W; Tizard R; Bixler SA; Rosa MD; Wallner BP
J Exp Med; 1993 Jul; 178(1):211-22. PubMed ID: 7686212
[TBL] [Abstract][Full Text] [Related]
15. Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation.
Bierer BE; Peterson A; Barbosa J; Seed B; Burakoff SJ
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1194-8. PubMed ID: 2448792
[TBL] [Abstract][Full Text] [Related]
16. CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling.
Kanner SB; Damle NK; Blake J; Aruffo A; Ledbetter JA
J Immunol; 1992 Apr; 148(7):2023-9. PubMed ID: 1372020
[TBL] [Abstract][Full Text] [Related]
17. Dissection of the human CD2 intracellular domain. Identification of a segment required for signal transduction and interleukin 2 production.
Chang HC; Moingeon P; Lopez P; Krasnow H; Stebbins C; Reinherz EL
J Exp Med; 1989 Jun; 169(6):2073-83. PubMed ID: 2567337
[TBL] [Abstract][Full Text] [Related]
18. Correlation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function-associated antigen 3.
Dustin ML; Olive D; Springer TA
J Exp Med; 1989 Feb; 169(2):503-17. PubMed ID: 2463330
[TBL] [Abstract][Full Text] [Related]
19. CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells.
Moingeon P; Lucich JL; McConkey DJ; Letourneur F; Malissen B; Kochan J; Chang HC; Rodewald HR; Reinherz EL
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1492-6. PubMed ID: 1346934
[TBL] [Abstract][Full Text] [Related]
20. Induction of negative signal through CD2 during antigen-specific T cell activation.
Ohno H; Nakamura T; Yagita H; Okumura K; Taniguchi M; Saito T
J Immunol; 1991 Oct; 147(7):2100-6. PubMed ID: 1680913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
